SKI Market

Indian Indices

Nifty

25,104.25 1.05
(0.00%)

Sensex

82,391.72 -53.49
( -0.06%)

Bank Nifty

56,629.10 -210.50
( -0.37%)

Nifty IT

38,300.00 630.80
( 1.67%)

Global Indices

Nasdaq

42,777.23 -6.65
(-0.02%)

Dow Jones

6,025.66 4.30
(0.07%)

Hang Seng

38,198.63 110.06
(0.29%)

Nikkei 225

8,853.08 20.80
(0.24%)

Forex

USD-INR

85.75 -0.02
(-0.02%)

EUR-INR

97.72 -0.17
(-0.18%)

GBP-INR

115.95 -0.20
(-0.17%)

JPY-INR

0.59 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

411.1031908

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

57.21

1138.33

EPS(TTM)

Face Value()

Div & Yield %

33.77

Back

Board of Remus Pharmaceuticals recommends final dividend

May 19,2025

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 17 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

25,104.25 1.05 (0.00%)

82,391.72 -53.49 ( -0.06%)

56,629.10 -210.50 ( -0.37%)

38,300.00 630.80 ( 1.67%)

42,777.23 -6.65 (-0.02%)

6,025.66 4.30 (0.07%)

38,198.63 110.06 (0.29%)

8,853.08 20.80 (0.24%)

85.75 -0.02 (-0.02%)

97.72 -0.17 (-0.18%)

115.95 -0.20 (-0.17%)

0.59 0.00 (-0.36%)